What the company does
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of …
What the weekly tape is saying
PEHA closed the latest completed week at 244.0 IDR. The 4-week return is -24.7% and the 12-week return is -8.3%. Trend Signal is inactive, Market Dynamics is -0.26. Setup signature: Risk-first tape with a 18/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 297.9 IDR
- Vs Trend Line
- -18.1%
- Fair Value
- 408.1 IDR
- Vs Fair Value
- -40.2%
- 52W High
- 460.0 IDR
- 52W Low
- 206.0 IDR
- Drawdown
- -47.0%
- Range Position
- 15.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 21
- 52W Active Breadth
- 40.4%
- Sector Scope
- ID Healthcare
- Sector Rank
- 9 of 37
- Sector Percentile
- 77.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
ID Healthcare
- Tracked Peers
- 37
- 4W Rank
- 29 of 37
- Avg 1W
- 3.8%
- Avg 4W
- -10.6%
- Trend Breadth
- 13.5%
- Positive MD
- 24.3%
ID Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 4
- 4W Rank
- 3 of 4
- Avg 1W
- 3.4%
- Avg 4W
- -19.5%
- Trend Breadth
- 25.0%
- Positive RS
- 75.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.26
- 4W MD Change
- -127.8%
- Relative Strength
- 0.03
- 4W RS Change
- -99.8%
- Expectation
- Negative
- Probability
- 39.42%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.1M
- 13W Average
- 6.1M
- 52W Average
- 2.2M
- Vs 13W
- 0.2x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.8%
- 52W Volatility
- 5.9%
- Upside Weeks
- 17
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 4.6% / -3.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JKT
- Country
- ID
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- IDR
- Market Cap
- 230.2B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 244.0 IDR | 6.1% | 297.9 IDR | 408.1 IDR | -0.26 | 0.03 | 1.1M | Off |
| 5 Jun 2026 | 230.0 IDR | -16.1% | 300.6 IDR | 410.8 IDR | 0.24 | 0.76 | 3.2M | Off |
| 29 May 2026 | 274.0 IDR | -4.9% | 303.9 IDR | 413.6 IDR | 0.76 | 9.54 | 1.5M | Off |
| 22 May 2026 | 288.0 IDR | -11.1% | 305.7 IDR | 416.2 IDR | 0.89 | 14.81 | 8.6M | Off |
| 15 May 2026 | 324.0 IDR | -12.9% | 307.4 IDR | 418.7 IDR | 0.93 | 18.85 | 39.1M | Off |
| 8 May 2026 | 372.0 IDR | 24.8% | 307.3 IDR | 420.9 IDR | 0.76 | 32.34 | 14.1M | Off |
| 1 May 2026 | 298.0 IDR | -0.7% | 305.8 IDR | 422.9 IDR | 0.61 | 6.95 | 952.6K | Off |
| 24 Apr 2026 | 300.0 IDR | -2.6% | 306.8 IDR | 425.2 IDR | 0.61 | 5.23 | 1.4M | Off |
| 17 Apr 2026 | 308.0 IDR | -0.6% | 307.5 IDR | 427.5 IDR | 0.14 | 0.94 | 613.7K | Off |
| 10 Apr 2026 | 310.0 IDR | 1.3% | 308.1 IDR | 429.8 IDR | -0.44 | 3.83 | 2.6M | Off |
| 3 Apr 2026 | 306.0 IDR | 16.8% | 308.9 IDR | 432.1 IDR | -1.03 | 8.69 | 4.1M | Off |
| 27 Mar 2026 | 262.0 IDR | -1.5% | 309.7 IDR | 434.3 IDR | -1.69 | -7.93 | 1.5M | Off |
| 20 Mar 2026 | 266.0 IDR | -3.6% | 311.9 IDR | 436.8 IDR | -1.66 | -7.09 | 566.9K | Off |
| 13 Mar 2026 | 276.0 IDR | -0.7% | 314.0 IDR | 439.4 IDR | -1.47 | -4.33 | 777.1K | Off |